secwatch.observer — SEC 8-K summary
======================================

Issuer:     Celularity Inc (CELU)
CIK:        0001752828
Form:       8-K
Filed at:   2022-09-23T23:59:59+00:00
Accession:  0001193125-22-250130
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Celularity retains former President Dr. Pecora as consultant and advisory co-chair
--------------------------------------------------------------------------------

- Dr. Pecora resigned as President effective Aug 31, 2022; consulting agreement signed Sept 21, 2022.
- Consulting fee: $10,000/month for six-month term, automatically renews for one additional six-month term.
- Separate scientific/clinical advisor agreement effective Sept 1, 2022: $10,000/month plus $125,000 in RSUs vesting over four years.
- Advisor agreement has a one-year term and may be renewed annually by mutual agreement.
- No other executive changes disclosed; Pecora remains involved in clinical development and advisory board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1752828/000119312522250130/0001193125-22-250130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1752828/000119312522250130/d255337d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-250130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer